Nuveen Asset Management, LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 86 filers reported holding UROGEN PHARMA LTD in Q2 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$891,512
+40.1%
63,634
+3.5%
0.00%
Q2 2023$636,132
-25.5%
61,462
-35.1%
0.00%
Q1 2022$854,000
-5.7%
94,660
+1.0%
0.00%
Q4 2021$906,000
-45.9%
93,752
-6.5%
0.00%
-100.0%
Q3 2021$1,674,000
+13.5%
100,316
+3.8%
0.00%
Q2 2021$1,475,000
-26.2%
96,600
-5.9%
0.00%
-100.0%
Q1 2021$2,000,000
-43.9%
102,654
-48.1%
0.00%0.0%
Q4 2020$3,562,000
-23.1%
197,690
-17.7%
0.00%
-50.0%
Q3 2020$4,635,000
-47.4%
240,248
-28.7%
0.00%
-50.0%
Q2 2020$8,807,000
+82.3%
337,149
+24.5%
0.00%
+100.0%
Q1 2020$4,831,000
+346.1%
270,833
+496.0%
0.00%
Q3 2019$1,083,000
-29.6%
45,444
+6.1%
0.00%
-100.0%
Q2 2019$1,539,00042,8260.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders